How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/juvenile-idiopathic-arthritis-with-polyarticular-course.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Juvenile Idiopathic Arthritis with Polyarticular Course — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Juvenile Idiopathic Arthritis with Polyarticular Course (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Juvenile Idiopathic Arthritis with Polyarticular Course, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
tumor necrosis factor inhibitors (TNFi)	tumor-necrosis-factor-inhibitors-tnfi	Pfizer	biologic	tumor necrosis factor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 1 drug in Juvenile Idiopathic Arthritis with Polyarticular Course

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Juvenile Idiopathic Arthritis with Polyarticular Course:

Cite this brief

Drug Landscape (2026). Juvenile Idiopathic Arthritis with Polyarticular Course — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/juvenile-idiopathic-arthritis-with-polyarticular-course. Accessed 2026-06-10.

Juvenile Idiopathic Arthritis with Polyarticular Course full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing